Mark Pearson - 16 Jun 2025 Form 4 Insider Report for Equitable Holdings, Inc. (EQH)

Role
President and CEO, Director
Signature
/s/ Michael Brudoley as attorney-in-fact for Mark Pearson
Issuer symbol
EQH
Transactions as of
16 Jun 2025
Net transactions value
-$1,131,738
Form type
4
Filing time
18 Jun 2025, 16:38:48 UTC
Previous filing
11 Jun 2025
Next filing
16 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pearson Mark President and CEO, Director C/O EQUITABLE HOLDINGS, INC., 1345 AVENUE OF THE AMERICAS, NEW YORK /s/ Michael Brudoley as attorney-in-fact for Mark Pearson 18 Jun 2025 0001512442

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EQH Common Stock Options Exercise $463,600 +20,000 +2.7% $23.18 754,367 16 Jun 2025 Direct F1, F2
transaction EQH Common Stock Sale $477,910 -9,029 -1.2% $52.93 745,338 16 Jun 2025 Direct F1, F2, F3
transaction EQH Common Stock Sale $585,607 -10,971 -1.5% $53.38 734,367 16 Jun 2025 Direct F1, F2, F4
transaction EQH Common Stock Sale $270,456 -5,105 -0.7% $52.98 729,262 16 Jun 2025 Direct F1, F2, F5
transaction EQH Common Stock Sale $261,366 -4,895 -0.67% $53.39 724,367 16 Jun 2025 Direct F1, F2, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EQH Employee Stock Option (right to buy) Options Exercise $0 -20,000 -5.5% $0.000000 346,400 16 Jun 2025 Common Stock 20,000 $23.18 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024.
F2 Includes Restricted Stock Units.
F3 This transaction was executed in multiple trades at prices ranging from $52.1950 to $53.1800. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $53.2000 to $53.5300. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $52.2500 to $53.2350. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
F6 This transaction was executed in multiple trades at prices ranging from $53.2500 to $53.5000. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.
F7 Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on February 26, 2021.